Navigation Links
Tobacco use linked to worse outcomes in HPV-positive head and neck cancer, U-M study finds
Date:2/15/2010

ANN ARBOR, Mich. Patients with head and neck cancer linked to high risk human papillomavirus, or HPV, have worse outcomes if they are current or former tobacco users, according to a new study from researchers at the University of Michigan Comprehensive Cancer Center.

High-risk HPVs are the same viruses that are associated with cancers of the uterine cervix.

The research suggests that current or former tobacco users may need a more aggressive treatment regimen than patients who have never used tobacco.

Past research shows that HPV-positive head and neck cancers tend to be more responsive to current treatments and these patients overall tend to have better outcomes than patients with HPV-negative tumors. However, the new study found that current tobacco users with HPV-positive tumors were five times more likely to have their cancer recur. Even former smokers had an increased risk of recurrence.

"Because the effect of HPV is so strong in giving a very good prognostic picture, we were surprised to find that smoking remained a huge issue, and it actually affected the outcome in patients who smoked," says senior study author Thomas Carey, Ph.D., professor of otolaryngology and pharmacology, and co-director of the Head and Neck Oncology Program at the U-M Comprehensive Cancer Center.

Results of the study appear in the Feb. 15 issue of Clinical Cancer Research.

The study looked at 124 patients with advanced oropharyngeal cancer, which is cancer of the tonsils or the base of the tongue. Most of these patients had HPV DNA in their tumors, which is consistent with HPV being a major factor in oropharyngeal cancer development. All 22 of the HPV-negative patients were tobacco users, and about two-thirds of the 102 HPV-positive patients were current or former tobacco users.

Of the HPV-positive patients who had never used tobacco, 6 percent had a recurrence of their cancer. Meanwhile, 19 percent of former tobacco users and 35 percent of current tobacco users had a recurrence. Still, the outcomes were better than the HPV-negative patients, all of whom were smokers, and among whom half recurred.

Tobacco users have traditionally been more likely than non-users to develop head and neck cancers. But a recent rise in these cancers linked to HPV has meant more non-smokers are being diagnosed with the disease. HPV-positive head and neck cancers tend to be more responsive to chemotherapy and radiation treatments, which has made researchers wonder if these highly toxic treatments could be reduced in this group of patients.

"The side effects of these treatments affect critical functions such as eating and swallowing. Since the HPV-positive tumors respond so well to treatment, our research team has been asking: Could we potentially spare patients some of these side effects while maintaining good outcomes if we reduce the doses given? If we decide to reduce intensity of treatment, our study shows we will want to take tobacco use into account. Any smoking or tobacco use increases the risk of recurrence or a second primary cancer," Carey says.

Researchers from U-M's multidisciplinary head and neck oncology program are planning a clinical trial to look at reducing treatment intensity for low-risk patients those whose tumors express certain markers, including HPV, and who are not tobacco users. The trial is expected to begin this spring.


'/>"/>

Contact: Nicole Fawcett
nfawcett@umich.edu
734-764-2220
University of Michigan Health System
Source:Eurekalert  

Related biology news :

1. Tobacco plant-made therapeutic thwarts West Nile virus
2. Tobacco plant thwarts caterpillar onslaught by opening flowers in the morning
3. Changing flowering times protect tobacco plants against insect herbivory
4. Engineered tobacco plants have more potential as a biofuel
5. Study confirms association between tobacco smoke and behavioral problems in children
6. Smokeless tobacco called moist snuff is contaminated with harmful substances
7. Exposure to lead, tobacco smoke raises risk of ADHD
8. Novel mechanism revealed for increasing recombinant protein yield in tobacco
9. Women more vulnerable to tobacco carcinogens, new results show
10. Tobacco makes medicine
11. Novel bioreactor enhances interleukin-12 production in genetically modified tobacco plants
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Tobacco use linked to worse outcomes in HPV-positive head and neck cancer, U-M study finds
(Date:4/28/2016)... April 28, 2016 First quarter 2016:   ... 966% compared with the first quarter of 2015 The ... 589.1 M (loss: 18.8) and the operating margin was 40% (-13) ... Cash flow from operations was SEK 249.9 M (21.2) ... guidance is unchanged, SEK 7,000-8,500 M. The operating margin ...
(Date:4/15/2016)... , April 15, 2016 ... the,  "Global Gait Biometrics Market 2016-2020,"  report to ... http://photos.prnewswire.com/prnh/20160330/349511LOGO ) , ,The global gait biometrics ... of 13.98% during the period 2016-2020. ... angles, which can be used to compute factors ...
(Date:3/29/2016)... March 29, 2016 LegacyXChange, Inc. ... "LEGX" and SelectaDNA/CSI Protect are pleased to announce our ... in a variety of writing instruments, ensuring athletes signatures ... created collectibles from athletes on LegacyXChange will be assured ... the DNA. Bill Bollander , CEO ...
Breaking Biology News(10 mins):
(Date:6/23/2016)... 23, 2016  Blueprint Bio, a company dedicated to ... medical community, has closed its Series A funding round, ... "We have received a commitment from Forentis ... need to meet our current goals," stated Matthew ... runway to complete validation on the current projects in ...
(Date:6/23/2016)... -- On Wednesday, June 22, 2016, the NASDAQ ... Dow Jones Industrial Average edged 0.27% lower to finish at ... Stock-Callers.com has initiated coverage on the following equities: Infinity Pharmaceuticals ... NKTR ), Aralez Pharmaceuticals Inc. (NASDAQ: ARLZ ... Learn more about these stocks by accessing their free trade ...
(Date:6/23/2016)... ... 23, 2016 , ... Regulatory Compliance Associates® Inc. (RCA), a ... webinar on Performing Quality Investigations: Getting to Root Cause. This ... charge. , Incomplete investigations are still a major concern to the Regulatory Authorities ...
(Date:6/23/2016)... June 22, 2016  Amgen (NASDAQ: AMGN ... QB3@953 life sciences incubator to accelerate the ... shared laboratory space at QB3@953 was created to help ... obstacle for many early stage organizations - access to ... sponsorship, Amgen launched two "Amgen Golden Ticket" awards, providing ...
Breaking Biology Technology: